<div class="pk-crumbs" data-crumbs="[{&quot;label&quot;:&quot;Drugs&quot;,&quot;href&quot;:&quot;README.md&quot;},{&quot;label&quot;:&quot;A02B&quot;,&quot;href&quot;:&quot;atc/A02B.md&quot;},{&quot;label&quot;:&quot;alginic acid&quot;}]"></div>

# alginic acid

- **generic name:** alginic acid
- **ATC codes:** `A02BX13`
- **DrugBank:** [DB13518](https://go.drugbank.com/drugs/DB13518) · **PubChem:** [CID 131704328](https://pubchem.ncbi.nlm.nih.gov/compound/131704328)
- **groups:** approved, investigational, withdrawn

## About

Alginic acid, a polysaccharide from brown algae, is used for acid-related disorders such as peptic ulcer and gastro-oesophageal reflux disease. It is an approved medicine, though some products have been withdrawn, and it is also being studied for other uses.

<small>Summary written by `glm-5.3-flash` from [Wikidata Q422092](https://www.wikidata.org/wiki/Q422092) and the WHO ATC classification; not checked by a person.</small>

## Extraction summary

| extracted at | time | popPK e/r/o | PD e/r/o (paper) | PGx e/r/o | tokens in/out | LLM | papers | GROBID/JATS | OA/non-OA | NONMEM |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-04 08:53 | 8:54 | 0/0/0 | 0/0/0 | 0/0/0 | 313,678/10,486 | ollama / qwen3.8:27b-mtp-q8_0 | 27 | 7/48 | 27/0 | 0 |

## popPK records

_not available_

<details class="legend">
<summary>Badge legend — what each badge means</summary>
<table><thead><tr><th>badge</th><th>what it means</th></tr></thead><tbody><tr><td><span class="pk-badge pk-badge--green">curated</span></td><td>hand-authored by a person — an exemplar, not an extraction.</td></tr><tr><td><span class="pk-badge pk-badge--green">extracted</span></td><td>the pipeline accepted the record: every closed-form check it could run passed.</td></tr><tr><td><span class="pk-badge pk-badge--green">reviewed — candidate</span></td><td>the reviewer ran the built model against the paper's own reported values and they agree — the best automatic verdict there is.</td></tr><tr><td><span class="pk-badge pk-badge--green">accepted (caveats)</span></td><td>the model replicates the paper, but an advisory check failed — the record page names the caveat under the badge and the drug page shows it under the status.</td></tr><tr><td><span class="pk-badge pk-badge--orange">needs review</span></td><td>extracted, then a check failed or a value looks implausible. The numbers are shown as read, not endorsed.</td></tr><tr><td><span class="pk-badge pk-badge--orange">built, not shipped</span></td><td>a model was built, but a core parameter fell back to a library default, so it is not shipped.</td></tr><tr><td><span class="pk-badge pk-badge--red">rejected</span></td><td>not accepted — the record is not a compartmental model, or nothing usable was extracted.</td></tr><tr><td><span class="pk-badge pk-badge--neutral">not modelled</span></td><td>pipeline state, not a judgement: no model has been built for this record yet (likewise `not simulated`).</td></tr><tr><td><span class="pk-badge pk-badge--stale">stale</span></td><td>the reviewer's verdict predates the latest re-run of the paper — treat the status as out of date, not as current.</td></tr><tr><td><span class="pk-badge pk-badge--green">cross-checked ✓</span></td><td>every independent reader agreed on every compared field. With more than one reader the badge counts them, e.g. 'cross-checked ✓ 2/2'.</td></tr><tr><td><span class="pk-badge pk-badge--orange">cross-check: partial</span></td><td>a reader differs on a non-structural field (a population label, a flag), or the readers do not all agree with each other.</td></tr><tr><td><span class="pk-badge pk-badge--red">cross-check: disputed</span></td><td>at least one reader differs on a structural parameter — a clearance, a volume, ka, a lag. The record still holds the FIRST reading; the disagreement is a signal for a reviewer, never an automatic correction.</td></tr><tr><td><span class="pk-badge pk-badge--species">rat</span></td><td>the data come from an animal (or in-vitro) study, not from people. The record, its model and its simulation are kept — they describe that species.</td></tr></tbody></table>
<p><small>The first badge is the record's <b>status</b> — what the pipeline and the reviewer concluded. A second badge, when present, is the <b>cross-check</b>: whether a model of another family, re-reading the same paper, extracted the same numbers. They are independent — a rejected record can be cross-checked, and a confirmed reading can still fail a plausibility check.</small></p>
</details>

## Coverage

- **PubMed hits:** 10543 matched, 137 returned
- **screened:** 1  ·  **relevant:** 0
- **records:** 0  ·  extracted 0  ·  needs_review 0  ·  rejected 0  ·  stale 0
- **scholar-agent fallback query used:** True

## Full text wanted

_1 paper(s) judged relevant from the abstract, with no full text on disk — paywalled, or the resolver could not reach them. Follow the DOI, then save the PDF into `papers/` as `&lt;save as&gt;.pdf` and re-run the extraction._

| save as | citation | domain | score | DOI | PubMed | why wanted |
|---|---|---|---|---|---|---|
| `Su_2026.pdf` | Su YC et al., Targeted hybrid nanogels for sialic aci…, International journal of bi… (2026) | pd | 4 | [10.1016/j.ijbiomac.2026.153003](https://doi.org/10.1016/j.ijbiomac.2026.153003) | [42276469](https://www.ncbi.nlm.nih.gov/pubmed/42276469) | metadata signals extractable PD data (IC50) |

<sub>queue written 2026-10-04T08:50:42.680515+00:00</sub>

## Screened and excluded

| domain | paper | verdict | relevance | extractability | reason |
|---|---|---|---|---|---|
| popPK | A_2021 | irrelevant | 2 | 0 | The study focuses on qualitative biodistribution and imaging of alginate in mice without reporting quantitative pharmacokinetic parameters like clearance, volume, or half-life. |
| popPK | Abd-Elghany_2024 | irrelevant | 0 | 0 | The study focuses on the pharmacokinetics of simvastatin, with alginate used only as a coating material for nanoparticles, not as the subject drug. |
| popPK | Atwal_2026 | irrelevant | 0 | 0 | The paper describes a drug delivery system (hydrogel) for cartilage regeneration, not a pharmacokinetic study of alginic acid as a subject drug. |
| popPK | Barry_2026 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of vancomycin, not alginic acid. |
| popPK | Barzel_2026 | irrelevant | 0 | 0 | The paper is a review of pharmacokinetic models for therapeutic enzymes in lysosomal storage diseases and does not mention alginic acid. |
| PD | Barzel_2026 | not_relevant | 3 | 0 | The paper is a review of therapeutic enzymes in lysosomal storage diseases and does not contain any data, analysis, or parameters for alginic acid. |
| popPK | Bayer_1992 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of alginase (an enzyme) and the clearance of P. aeruginosa bacteria, not the pharmacokinetic parameters of alginic acid as a drug. |
| popPK | Cao_2016 | irrelevant | 0 | 0 | The study investigates the diffusion and binding of tobramycin in an alginate biofilm model, not the pharmacokinetics of alginic acid as a drug. |
| popPK | Chen_2022 | irrelevant | 0 | 0 | The paper focuses on the recovery of alginate-like exopolysaccharides from wastewater sludge, not the pharmacokinetics of alginic acid in a biological system. |
| popPK | Chen_2022_2 | irrelevant | 0 | 0 | The study focuses on the formulation and in vitro release of quercetin nanoparticles using alginate sodium as a carrier, not the pharmacokinetics of alginic acid itself. |
| popPK | Chirizzi_2025 | irrelevant | 0 | 0 | The study focuses on paclitaxel delivery using alginate as a carrier material, not the pharmacokinetics of alginic acid itself. |
| popPK | Cohen_1991 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of bovine serum albumin (BSA) as a model antigen delivered via alginate microcapsules, not the pharmacokinetics of alginic acid itself. |
| popPK | Delavenne_2026 | irrelevant | 0 | 0 | The study focuses on the pharmacokinetics of rFIX-FP (Factor IX) in haemophilia B patients, not alginic acid. |
| PD | Delavenne_2026 | not_relevant | 0 | 0 | The paper reports a population pharmacokinetic (PK) model validation for rFIX-FP but does not report any pharmacodynamic (PD) or exposure-response relationship, as the drug's effect (hemostasis) is managed via target concentration thresholds rather than a modeled effect-response curve. |
| popPK | Eivazzadeh-Keihan_2023 | irrelevant | 0 | 0 | The paper describes the fabrication and characterization of a magnetic nanocomposite scaffold for hyperthermia, not the pharmacokinetics of alginic acid. |
| popPK | El-Ashmawy_2021 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of gliclazide, not alginic acid. |
| popPK | El_2026 | irrelevant | 0 | 0 | The study reports pharmacokinetic parameters for ciprofloxacin, not alginic acid. |
| PD | El_2026 | not_relevant | 0 | 0 | The paper focuses on the pharmacokinetics of ciprofloxacin and its exposure-response to a static AUC/MIC target, not on the pharmacodynamics of alginic acid. |
| popPK | Eleveld_2026 | irrelevant | 0 | 0 | The paper is a methodological comparison of software tools (OpenPMX vs NONMEM) and does not report pharmacokinetic parameters for alginic acid. |
| PD | Eleveld_2026 | not_relevant | 0 | 0 | The paper is a software validation study comparing estimation precision of OpenPMX vs NONMEM using simulated PK/PD datasets; it does not report a specific pharmacodynamic relationship or numeric PD parameters for alginic acid. |
| popPK | Fei_2025 | irrelevant | 0 | 0 | The study focuses on a biomaterial hydrogel for pulp regeneration and does not report pharmacokinetic parameters for alginic acid. |
| popPK | Fleten_2022 | irrelevant | 0 | 0 | The study focuses on alginate as a drug delivery vehicle for cabazitaxel, not on the pharmacokinetics of alginic acid itself. |
| popPK | Fresquet-Molina_2025 | irrelevant | 0 | 0 | The paper is a systematic review of vancomycin pharmacokinetics, not alginic acid. |
| PD | Fresquet-Molina_2025 | not_relevant | 0 | 0 | The paper is a systematic review of pharmacokinetic (PK) models for vancomycin and does not report any pharmacodynamic (PD) or exposure-response relationships for alginic acid or any other drug. |
| popPK | Gallo_2017 | irrelevant | 0 | 0 | The study focuses on the formulation and in vitro characterization of sodium cromoglycate microparticles, not the pharmacokinetics of alginic acid. |
| PD | Garnett_1993 | not_relevant | 1 | 0 | The text is a general review of GERD management that mentions alginic acid only as a drug class without providing any specific pharmacodynamic data, exposure-response relationships, or numeric parameters. |
| popPK | Ghumman_2018 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of oxcarbazepine, using alginate only as a formulation excipient, not as the subject drug. |
| popPK | Goeyvaerts_2026 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of mosnodenvir (a dengue antiviral), not alginic acid. |
| popPK | Govan_1983 | irrelevant | 0 | 0 | The study investigates the pulmonary survival of Pseudomonas aeruginosa bacteria in rats, not the pharmacokinetics of alginic acid as a drug. |
| popPK | Guidi_2026 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of isavuconazole, not alginic acid. |
| popPK | Guo_2026 | irrelevant | 0 | 0 | The study focuses on the pharmacokinetics and pharmacodynamics of colistin and imipenem, not alginic acid. |
| popPK | Han_2024 | irrelevant | 0 | 0 | The study investigates the biological effects of alginate hydrogels on senescent cells, not the pharmacokinetics of alginic acid. |
| popPK | Hanke_2026 | irrelevant | 0 | 0 | The study reports pharmacokinetic parameters for iclepertin, not alginic acid. |
| popPK | Hattab_1981 | irrelevant | 0 | 0 | The study measures the pharmacokinetics of fluoride (a component/impurity) from alginate impression materials, not the pharmacokinetic parameters of alginic acid itself. |
| popPK | Hoeben_2026 | irrelevant | 0 | 0 | The paper studies the pharmacokinetics of calaspargase pegol (CalPEG), not alginic acid. |
| popPK | Horhota_1976 | irrelevant | 0 | 0 | The study investigates the physical stability and dissolution of tablet formulations containing an alginate derivative as a disintegrant, not the pharmacokinetics of alginic acid. |
| popPK | Hsu_2026 | irrelevant | 0 | 0 | The paper is a methodological simulation study on covariate identification in PopPK modeling and does not report pharmacokinetic parameters for alginic acid. |
| PD | Hsu_2026 | not_relevant | 0 | 0 | The paper focuses on population pharmacokinetic (PopPK) covariate identification methods and simulation power, with no mention of alginic acid or any pharmacodynamic (PD) or exposure-response analysis. |
| popPK | Huang_2024 | irrelevant | 0 | 0 | The study focuses on the preparation and in vitro release of astaxanthin microcapsules using alginate as a coating material, not on the pharmacokinetics of alginic acid. |
| popPK | Huang_2026 | irrelevant | 0 | 0 | The paper is a methodological study evaluating an automated PopPK modeling framework (nlmixr2auto) on 22 unspecified clinical datasets and does not report specific PK parameters for alginic acid. |
| PD | Huang_2026 | not_relevant | 0 | 0 | The paper focuses on automated population pharmacokinetic (PopPK) modeling methods and does not report any pharmacodynamic (PD) or exposure-response relationships for alginic acid or any other drug. |
| popPK | Husheng_2026 | irrelevant | 0 | 0 | The paper is a review of vancomycin pharmacokinetics, not alginic acid. |
| PD | Husheng_2026 | not_relevant | 0 | 0 | The paper is a review of population pharmacokinetic (PK) models for vancomycin and does not report any pharmacodynamic (PD) or exposure-response relationships for alginic acid or any other drug. |
| PD | Ibrahim_2025 | not_relevant | 0 | 0 | The paper focuses on the extraction and characterization of mango peel bioactive compounds and their antimicrobial/antioxidant properties; it does not report a pharmacodynamic or exposure-response relationship for alginic acid. |
| popPK | Jaafar_2019 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of insulin delivered via alginate nanoparticles, not the pharmacokinetics of alginic acid itself. |
| popPK | Jia_2026 | irrelevant | 0 | 0 | The study reports population pharmacokinetic parameters for rivaroxaban, not alginic acid. |
| PD | Jia_2026 | not_relevant | 0 | 0 | The paper reports a population pharmacokinetic (PopPK) model for rivaroxaban, not alginic acid, and does not provide a pharmacodynamic (PD) model or numeric PD parameters (e.g., Emax, EC50). |
| popPK | Jiao_2024 | irrelevant | 0 | 0 | The paper focuses on the mechanical properties and 3D bioprinting of alginate-based materials for artificial blood vessels, not the pharmacokinetics of alginic acid. |
| popPK | Jin_2026 | irrelevant | 0 | 0 | The paper describes a biomaterial (hydrogel) for bone regeneration and does not report pharmacokinetic parameters for alginic acid. |
| popPK | Johansen_1994 | irrelevant | 0 | 0 | The study investigates bacterial clearance of Pseudomonas aeruginosa in rats, not the pharmacokinetics of alginic acid. |
| popPK | Johansen_1994_2 | irrelevant | 0 | 0 | The study is an immunological investigation of Pseudomonas aeruginosa vaccines in rats and does not report pharmacokinetic parameters for alginic acid. |
| popPK | Jovanović_2026 | irrelevant | 0 | 0 | The study focuses on the pharmacokinetics of adalimumab, not alginic acid. |
| PD | Jovanović_2026 | not_relevant | 0 | 0 | The paper focuses exclusively on the population pharmacokinetics (PK) of Adalimumab, reporting parameters like clearance and volume of distribution, but contains no pharmacodynamic (PD) or exposure-response modeling. |
| popPK | Ju_2023 | irrelevant | 0 | 0 | The paper is a review on extracellular vesicle-loaded hydrogels for tissue repair and does not contain any pharmacokinetic data for alginic acid. |
| popPK | Karabasz_2019 | irrelevant | 0 | 0 | The study investigates the toxicity and anticancer activity of an alginate-curcumin conjugate in mice, not the pharmacokinetics of alginic acid. |
| popPK | Karakas_2022 | irrelevant | 0 | 0 | The study focuses on the formulation and in-vitro release of ellagic acid from alginate-pectin beads, not the pharmacokinetics of alginic acid. |
| popPK | Karlsen_2026 | irrelevant | 0 | 0 | The paper describes a general framework for benchmarking covariate model building methods using simulated datasets and does not report specific pharmacokinetic parameters for alginic acid. |
| PD | Karlsen_2026 | not_relevant | 0 | 0 | The paper describes a framework for benchmarking covariate model building in population pharmacokinetics (popPK) using simulated data; it does not report any pharmacodynamic (PD) or exposure-response relationships for alginic acid or any other drug. |
| popPK | Kawashima_1989 | irrelevant | 0 | 0 | The provided evidence contains only software metadata and no scientific content regarding alginic acid pharmacokinetics. |
| popPK | Kawashima_1990 | irrelevant | 0 | 0 | The provided evidence contains only software metadata and no scientific content regarding alginic acid pharmacokinetics. |
| popPK | Kim_2021 | irrelevant | 0 | 0 | The paper studies the inhibition of alginate synthesis in Pseudomonas aeruginosa by ebselen analogues, not the pharmacokinetics of alginic acid. |
| popPK | Kim_2022 | irrelevant | 0 | 0 | The study focuses on the in vivo fate of bacteriophages encapsulated in alginate microspheres, not the pharmacokinetics of alginic acid itself. |
| popPK | Kim_2026 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of bevacizumab (CT-P16), not alginic acid. |
| PD | Kim_2026 | not_relevant | 0 | 0 | The paper reports a population pharmacokinetic (PK) model for bevacizumab (CT-P16) and compares PK parameters, but it does not report a pharmacodynamic (PD) model or exposure-response relationship with numeric PD parameters (e.g., Emax, EC50); it only references a published exposure benchmark for context. |
| PD | Klöck_1997 | not_relevant | 0 | 0 | The paper reports qualitative biocompatibility and lack of mitogenic activity for alginic acid, but provides no numeric concentration-effect or dose-response data. |
| PD | Kolahdoozan_2024 | not_relevant | 2 | 1 | The paper focuses on optimizing extraction parameters (temperature, time, power) to maximize antioxidant activity (DPPH) and does not report a pharmacokinetic or pharmacodynamic exposure-response relationship for the drug in a biological system. |
| popPK | Kong_2025 | irrelevant | 0 | 0 | The paper describes a software framework (PKPy) and uses Theophylline as a validation dataset, not alginic acid. |
| PD | Kong_2025 | not_relevant | 0 | 0 | The paper describes a pharmacokinetic (PK) software framework and analyzes theophylline PK data; it contains no pharmacodynamic (PD) or exposure-response analysis for alginic acid or any other drug. |
| popPK | Kou_2024 | irrelevant | 0 | 0 | The study focuses on the pharmacokinetics and efficacy of tetrandrine, with alginate serving only as a delivery vehicle (nanogel) rather than the subject drug. |
| popPK | Kovach_2017 | irrelevant | 0 | 0 | The paper studies the mechanical properties of bacterial biofilms (specifically Pseudomonas aeruginosa) and their polysaccharide components (alginate, Psl, Pel), not the pharmacokinetics of the drug alginic acid. |
| popPK | Kumar_2023 | irrelevant | 0 | 0 | The study focuses on the hemostatic and wound healing efficacy of an alginate hydrogel, not the pharmacokinetic disposition parameters (CL, V, etc.) of alginic acid. |
| popPK | Kwack_2026 | irrelevant | 0 | 0 | The study focuses on warfarin, theophylline, and tobramycin, not alginic acid. |
| PD | Kwack_2026 | not_relevant | 0 | 0 | The paper focuses on automated population pharmacokinetic (PopPK) modeling for warfarin, theophylline, and tobramycin, and does not report any pharmacodynamic (PD) or exposure-response relationships for alginic acid. |
| popPK | Li_2026 | irrelevant | 0 | 0 | The study focuses on the therapeutic efficacy of a sodium alginate hydrogel for gastric ulcers and does not report pharmacokinetic parameters for alginic acid. |
| popPK | Liang_2026 | irrelevant | 0 | 0 | The study focuses on the pharmacokinetics of remimazolam tosilate, not alginic acid. |
| PD | Liang_2026 | not_relevant | 0 | 0 | The paper focuses exclusively on pharmacokinetic (PopPK and PBPK) modeling for dose recommendation and does not report any pharmacodynamic or exposure-response analysis. |
| PD | Liew_2006 | not_relevant | 0 | 0 | The paper focuses on pharmaceutical formulation and drug release kinetics from alginate matrices, not on the pharmacodynamic (exposure-response) relationship of alginic acid itself. |
| popPK | Lin_2024 | irrelevant | 0 | 0 | The study focuses on the formulation and in-vitro release of curcumin tablets where sodium alginate is used as an excipient, not on the pharmacokinetics of alginic acid. |
| popPK | Liu_2024 | irrelevant | 0 | 0 | The study focuses on rutin delivery using sodium alginate as a formulation component, not on the pharmacokinetics of alginic acid itself. |
| PD | Luciani-Giacobbe_2021 | not_relevant | 0 | 0 | The paper reports pharmacokinetic (bioavailability) and dissolution data, but does not provide a pharmacodynamic (exposure-response or dose-response) analysis or numeric PD parameters. |
| popPK | Ma_2023 | irrelevant | 0 | 0 | The paper describes the synthesis of a sodium alginate sponge for microplastic removal and reports no pharmacokinetic parameters. |
| popPK | Madgulkar_2018 | irrelevant | 0 | 0 | The study focuses on the pharmacokinetics of lopinavir, using alginic acid only as a formulation excipient for microspheres. |
| popPK | Mamdouh_2019 | irrelevant | 0 | 0 | The study focuses on the formulation of nimodipine using sodium alginate as an excipient, not on the pharmacokinetics of alginic acid itself. |
| popPK | Masoumi_2020 | irrelevant | 0 | 0 | The study focuses on buprenorphine and rifampin nanoparticles where alginate is a carrier material, not a subject drug for PK analysis. |
| popPK | McKellar_1990 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of fenbendazole in dogs, where alginate is only used as a formulation vehicle, not as the subject drug. |
| popPK | Moghadam_1990 | irrelevant | 0 | 0 | The paper describes a dental technique for fabricating provisional restorations using alginate impressions and does not involve the pharmacokinetics of alginic acid. |
| popPK | Moghadamnia_2019 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of ibuprofen, using alginate only as a formulation excipient, not as the subject drug. |
| popPK | Mori_2018 | irrelevant | 0 | 0 | The study focuses on the formulation and physicochemical characterization of beta-carotene hydrogels using sodium alginate as a stabilizer, not on the pharmacokinetics of alginic acid. |
| PD | Murata_2016 | not_relevant | 0 | 0 | The paper investigates the effect of alginic acid on the dissolution rate of valsartan from film dosage forms, which is a pharmaceutical formulation/dissolution study, not a pharmacodynamic (exposure-response) or dose-response analysis of alginic acid's biological effect. |
| popPK | Naeem_2023 | irrelevant | 0 | 0 | The study focuses on the formulation and in vitro characterization of a drug delivery system for puerarin, not the pharmacokinetics of alginic acid. |
| popPK | Nazarov_1988 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of gentamicin (the antibiotic) released from alginic acid implants, not the pharmacokinetics of alginic acid itself. |
| popPK | Niu_2019 | irrelevant | 0 | 0 | The study focuses on the pharmacokinetics of diclofenac sodium (the drug payload), not alginic acid (the delivery vehicle). |
| popPK | Noureen_2022 | irrelevant | 0 | 0 | The study focuses on the formulation and in vitro release of tramadol from alginate microspheres, not the pharmacokinetics of alginic acid itself. |
| popPK | Ooi_2026 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of elafibranor and its metabolite GFT1007, not alginic acid. |
| popPK | P_2016 | irrelevant | 0 | 0 | The study focuses on curcumin delivery using alginate nanogels and does not report pharmacokinetic parameters for alginic acid. |
| popPK | Redman_2021 | irrelevant | 0 | 0 | The study investigates glycoside hydrolases for biofilm dispersal and does not report pharmacokinetic parameters for alginic acid. |
| popPK | Ristow_1982 | irrelevant | 0 | 0 | The study investigates the effect of sodium alginate (a fiber) on folic acid bioavailability in chicks, not the pharmacokinetics of alginic acid itself. |
| PD | Sanchez-Ballester_2021 | not_relevant | 0 | 0 | The paper is a review of alginic acid as a pharmaceutical excipient focusing on structure-property relationships for tablet formulation, not pharmacodynamic or exposure-response relationships. |
| popPK | Sattar_2024 | irrelevant | 0 | 0 | The study focuses on the in-vitro formulation and release of ciprofloxacin from alginate nanocarriers, not the pharmacokinetics of alginic acid itself. |
| popPK | Schweizer_2013 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of a monoclonal antibody delivered via alginate-based systems, not the pharmacokinetics of alginic acid itself. |
| popPK | Seth_2017 | irrelevant | 0 | 0 | The study focuses on the pharmacokinetics of a dipeptidyl peptidase-IV inhibitor delivered via chitosan-alginate beads, not alginic acid itself. |
| popPK | Sethuramalingam_2026 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of asparaginase, not alginic acid. |
| PD | Sethuramalingam_2026 | not_relevant | 0 | 0 | The paper focuses on the pharmacokinetics of asparaginase and does not contain any data, analysis, or mention of alginic acid. |
| PD | Sharma_2017 | not_relevant | 0 | 0 | The paper describes the adsorption of a metal ion by a nanohydrogel, which is a physicochemical process, not a pharmacodynamic drug-response relationship. |
| popPK | Shinde_2014 | irrelevant | 0 | 0 | The study focuses on the formulation and delivery of azelastine using alginate microspheres, not the pharmacokinetics of alginic acid itself. |
| popPK | Shiraishi_1991 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of indomethacin using alginate as a formulation excipient, not the pharmacokinetics of alginic acid itself. |
| popPK | Shiraishi_1993 | irrelevant | 0 | 0 | The provided evidence contains only metadata and software version information, with no scientific content or pharmacokinetic data for alginic acid. |
| popPK | Song_2022 | irrelevant | 0 | 0 | no_text gate: only 95 chars of text extracted (&lt; 400) |
| PD | Su_2026 | not_relevant | 3 | 2 | The paper reports an IC50 value for the nanogel formulation, which is a dose-response parameter, but it does not provide a formal PK/PD model, exposure-response analysis, or detailed concentration-effect curve for alginic acid itself; the focus is on nanocarrier design and efficacy rather than pharmacodynamic modeling. |
| popPK | Sunnåker_2026 | irrelevant | 0 | 0 | The study reports population pharmacokinetic parameters for mitiperstat, not alginic acid. |
| PD | Sunnåker_2026 | not_relevant | 0 | 0 | The paper reports a population pharmacokinetic (popPK) model for mitiperstat, not alginic acid, and contains no pharmacodynamic (PD) or exposure-response analysis. |
| popPK | Surendran_2022 | irrelevant | 0 | 0 | The study focuses on rutin-loaded chitosan-alginate nanoparticles for antidiabetic effects, not the pharmacokinetics of alginic acid itself. |
| popPK | Suthahar_2026 | irrelevant | 0 | 0 | The paper is a systematic review of pharmacokinetic models for 5-fluorouracil, not alginic acid. |
| PD | Suthahar_2026 | not_relevant | 0 | 0 | The paper is a systematic review of population pharmacokinetic (PK) models for 5-fluorouracil and does not report any pharmacodynamic (PD) or exposure-response relationships for alginic acid or any other drug. |
| PD | Syad_2013 | not_relevant | 0 | 0 | The paper reports in vitro enzyme inhibition (IC50) of crude extracts, not a pharmacodynamic exposure-response relationship for the specific drug alginic acid in a biological system. |
| popPK | Sürmelioğlu_2026 | irrelevant | 0 | 0 | The paper is a systematic review of vancomycin pharmacokinetics, not alginic acid. |
| PD | Sürmelioğlu_2026 | not_relevant | 0 | 0 | The paper is a systematic review of population pharmacokinetic (PopPK) studies for vancomycin, not alginic acid, and focuses on PK parameters (clearance, volume) rather than pharmacodynamic (PD) or exposure-response relationships. |
| PD | Taha_2005 | not_relevant | 0 | 0 | The paper describes the synthesis and in vitro drug release kinetics of alginic acid beads, not a pharmacodynamic or exposure-response relationship for the drug itself. |
| popPK | Tan_2026 | irrelevant | 0 | 0 | The study focuses on the pharmacokinetics of 5-fluorouracil, not alginic acid. |
| PD | Tan_2026 | not_relevant | 0 | 0 | The paper focuses exclusively on the population pharmacokinetic (PK) modeling of 5-fluorouracil (5-FU) and does not contain any pharmacodynamic (PD) or exposure-response analysis for alginic acid or any other drug. |
| popPK | Trinh_2023 | irrelevant | 0 | 0 | The study focuses on the development of alginate-based hydrogels for acetaminophen delivery and does not report pharmacokinetic parameters for alginic acid itself. |
| popPK | Tulbah_2026 | irrelevant | 0 | 0 | The paper is a review of PKPD models for anesthetic agents (e.g., fentanyl, propofol) and does not contain data for alginic acid. |
| PD | Tulbah_2026 | not_relevant | 0 | 0 | The paper is a review of PK/PD models for anesthetic agents (propofol, remifentanil, fentanyl, etc.) and does not contain any data, analysis, or parameters for alginic acid. |
| popPK | Wafa_2021 | irrelevant | 0 | 0 | The study investigates the ocular delivery of pilocarpine nitrate using sodium alginate as a polymer excipient, not the pharmacokinetics of alginic acid itself. |
| PD | Wang_2018 | not_relevant | 0 | 0 | The paper focuses on the formulation, stability, and qualitative antitumor efficacy of nanogels, without reporting any quantitative pharmacodynamic or exposure-response models or numeric PD parameters. |
| popPK | Wang_2019 | irrelevant | 0 | 0 | The study focuses on the formulation and release of curcumin from alginate beads, not the pharmacokinetics of alginic acid itself. |
| popPK | Wang_2022 | irrelevant | 0 | 0 | The study focuses on a drug delivery vehicle (film) using sodium alginate as a component, not on the pharmacokinetics of alginic acid itself. |
| popPK | Wang_2024 | irrelevant | 0 | 0 | The paper describes a biomaterial hydrogel for intervertebral disc repair and does not report pharmacokinetic parameters for alginic acid. |
| popPK | Wang_2024_2 | irrelevant | 0 | 0 | The study focuses on the pharmacokinetics of rapeseed-derived peptides (RPPs) encapsulated in a chitosan/sodium alginate nanocarrier, not the pharmacokinetics of alginic acid itself. |
| popPK | Wang_2025 | irrelevant | 0 | 0 | The paper describes a drug delivery system using sodium alginate as a hydrogel matrix for cancer treatment, not a pharmacokinetic study of alginic acid. |
| popPK | Wang_2026 | irrelevant | 0 | 0 | The paper focuses on population pharmacokinetic models for polymyxin B, not alginic acid. |
| PD | Wang_2026 | not_relevant | 0 | 0 | The paper focuses exclusively on population pharmacokinetic (PK) modeling of polymyxin B and does not report any pharmacodynamic (PD) or exposure-response relationships for alginic acid. |
| popPK | Winkler_1985 | irrelevant | 0 | 0 | The paper discusses Pseudomonas aeruginosa infections in cystic fibrosis and mentions alginate as a bacterial exopolysaccharide, but does not study the pharmacokinetics of alginic acid as a drug. |
| popPK | Woods_1985 | irrelevant | 0 | 0 | The study investigates the immunological properties of alginate as a protective immunogen against Pseudomonas aeruginosa infection, not the pharmacokinetic disposition of alginic acid. |
| popPK | Wu_2023 | irrelevant | 0 | 0 | The study focuses on sodium alginate as a coating material for liposomes in an in vitro context, not on the pharmacokinetics of alginic acid itself. |
| PD | Wu_2025 | not_relevant | 0 | 0 | The paper describes the synthesis of a modified alginate hydrogel for heavy metal adsorption and reports adsorption isotherm/kinetic parameters, which are physicochemical material properties, not pharmacodynamic (drug exposure-response) relationships. |
| popPK | Wu_2026 | irrelevant | 0 | 0 | The study reports population pharmacokinetic parameters for bosutinib, not alginic acid. |
| PD | Wu_2026 | not_relevant | 0 | 0 | The paper reports a population pharmacokinetic (PK) model for bosutinib, not alginic acid, and contains no pharmacodynamic (PD) or exposure-response analysis. |
| popPK | Xajil-Ramos_2026 | irrelevant | 0 | 0 | The study reports pharmacokinetic parameters for tacrolimus, not alginic acid. |
| PD | Xajil-Ramos_2026 | not_relevant | 0 | 0 | The paper reports a population pharmacokinetic (PopPK) model for tacrolimus, not alginic acid, and contains no pharmacodynamic or exposure-response analysis. |
| popPK | Xie_2026 | irrelevant | 0 | 0 | The paper focuses on the pharmacokinetics of daptomycin, not alginic acid. |
| PD | Xie_2026 | not_relevant | 0 | 0 | The paper focuses on daptomycin population pharmacokinetics (PopPK) and precision dosing, not alginic acid, and does not report pharmacodynamic (PD) or exposure-response parameters. |
| popPK | Xu_2026 | irrelevant | 0 | 0 | The study focuses on the pharmacokinetics of polymyxin B, not alginic acid. |
| PD | Xu_2026 | not_relevant | 0 | 0 | The paper focuses on pharmacokinetic (PK) modeling and exposure prediction (AUC) for polymyxin B, with no pharmacodynamic (PD) or exposure-response analysis reported. |
| popPK | Yomota_1994 | irrelevant | 0 | 0 | The provided evidence contains only software metadata and no scientific content regarding alginic acid pharmacokinetics. |
| popPK | Yu_2019 | irrelevant | 0 | 0 | The study focuses on alginate as a coating material for a vaccine delivery system, not on the pharmacokinetics of alginic acid itself. |
| popPK | Zaidi_2026 | irrelevant | 0 | 0 | The paper is a systematic review of opioid pharmacokinetics in pregnancy and does not study alginic acid. |
| PD | Zaidi_2026 | not_relevant | 0 | 0 | The paper is a systematic review of opioid pharmacokinetics in pregnancy and does not contain any data, analysis, or parameters for alginic acid. |
| popPK | Zhang_2024 | irrelevant | 0 | 0 | The study focuses on the formulation and physical characterization of a salidroside emulsion using sodium alginate as a stabilizer, not on the pharmacokinetics of alginic acid. |
| popPK | Zhang_2026 | irrelevant | 0 | 0 | The study focuses on the pharmacokinetics of linezolid, not alginic acid. |
| PD | Zhang_2026 | not_relevant | 0 | 0 | The paper focuses on population pharmacokinetics (PopPK) and machine learning for concentration prediction of linezolid, with no pharmacodynamic (PD) modeling, exposure-response analysis, or numeric PD parameters reported. |
| popPK | Zhenyan_2026 | irrelevant | 0 | 0 | The paper is a systematic review of rituximab pharmacokinetics, not alginic acid. |
| PD | Zhenyan_2026 | not_relevant | 0 | 0 | The paper is a systematic review of pharmacokinetics (PK) for rituximab, not alginic acid, and contains no pharmacodynamic (PD) or exposure-response modeling. |
| popPK | Zhong_2020 | irrelevant | 0 | 0 | The study focuses on the pharmacokinetics of doxorubicin (DOX) encapsulated in alginate nanoparticles, not the pharmacokinetics of alginic acid itself. |
| popPK | Zou_2021 | irrelevant | 0 | 0 | The study focuses on the pharmacokinetics of cyanidin-3-O-glucoside (C3G) using alginate as a delivery vehicle, not on the pharmacokinetic parameters of alginic acid itself. |
| popPK | Zussman_2022 | irrelevant | 0 | 0 | The study focuses on metronidazole release from alginate hydrogels, not the pharmacokinetics of alginic acid itself. |
| PD | unknown_1991 | not_relevant | 1 | 0 | The paper is a clinical trial comparing fixed-dose combinations and reports only qualitative symptom improvements and healing rates, with no concentration-effect data, PK/PD modeling, or numeric PD parameters. |
| popPK | van_2026 | irrelevant | 0 | 0 | The paper is a systematic review of pharmacokinetics for immunoglobulins (IgG), not alginic acid. |
| PD | van_2026 | not_relevant | 0 | 0 | The paper is a systematic review of pharmacokinetic models for immunoglobulins (IVIg/SCIg) and does not contain any data, analysis, or parameters for alginic acid. |

---
<sub>Generated by `docs.py` (scholarv2)</sub>
